TY - JOUR T1 - Correction to “G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer” JF - Molecular Pharmacology JO - Mol Pharmacol SP - 628 LP - 628 DO - 10.1124/mol.116.107185err VL - 92 IS - 6 A2 - , Y1 - 2017/12/01 UR - http://molpharm.aspetjournals.org/content/92/6/628.abstract N2 - ER -